Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.

Autor: Heslop HE; Baylor College of Medicine, Houston, Texas. Electronic address: hheslop@bcm.edu., Stadtmauer EA; University of Pennsylvania, Philadelphia, Pennsylvania., Levine JE; Icahn School of Medicine at Mount Sinai, New York, New York., Ballen KK; University of Virginia, Charlottesville, Virginia., Chen YB; Massachusetts General Hospital, Boston, Massachusetts., DeZern AE; Johns Hopkins University, Baltimore, Maryland., Eapen M; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota., Hamadani M; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota., Hamilton BK; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Hari P; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota., Jones RJ; Johns Hopkins University, Baltimore, Maryland., Logan BR; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota., Kean LS; Boston Children's Hospital, Boston, Massachusetts., Leifer ES; National Institutes of Health, Bethesda, Maryland., Locke FL; Moffitt Cancer Center & Research Institute, Tampa, Florida., Maziarz RT; Oregon Health & Science University, Portland, Oregon., Nemecek ER; Oregon Health & Science University, Portland, Oregon., Pasquini M; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota., Phelan R; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota., Riches ML; University of North Carolina, Durham, North Carolina., Shaw BE; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota., Walters MC; University of California San Francisco, San Francisco, California., Foley A; National Marrow Donor Program, Minneapolis, Minnesota., Devine SM; National Marrow Donor Program, Minneapolis, Minnesota., Horowitz MM; Center for International Blood & Marrow Transplant Research, Minneapolis, Minnesota.
Jazyk: angličtina
Zdroj: Transplantation and cellular therapy [Transplant Cell Ther] 2021 Nov; Vol. 27 (11), pp. 885-907. Date of Electronic Publication: 2021 Aug 27.
DOI: 10.1016/j.jtct.2021.08.016
Abstrakt: In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.
(Copyright © 2021 The American Society for Transplantation and Cellular Therapy. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: